Relatório global de análise de tamanho, participação e análise de tendências do mercado de diagnóstico molecular de ponto de cuidado – Visão geral do setor e previsão para 2031

Análise de mercado de diagnóstico molecular point of care

O aumento do foco dos investigadores e cientistas na aplicação de uma vasta gama de testes para detetar sequências específicas em ADN ou ARN levou à aplicação em larga escala de diagnósticos moleculares no local de prestação de cuidados. Estes testes de diagnóstico molecular no local de atendimento ajudam a diagnosticar as alterações num gene ou cromossoma que podem causar ou afetar a probabilidade de desenvolver uma doença específica. Qualquer alteração neste caso pode levar a distúrbios e doenças como o cancro.                                        

Mercado de tamanho de diagnóstico molecular de ponto de atendimento

O tamanho global do mercado de diagnóstico molecular no ponto de atendimento foi avaliado em 3,86 mil milhões de dólares em 2023 e deverá atingir os 10,55 mil milhões de dólares até 2031, com um CAGR de 13,4% durante o período de previsão de 2024 a 2031.

Âmbito do relatório e segmentação de mercado       

Point of Care Molecular Diagnostics Market Definition

Point of care molecular diagnostics are the diagnostic tests that are conducted to diagnose and detect infectious diseases in patients these are fast, reliable and offer a greater degree of reach. Owing to their faster results, the point of care molecular diagnostics help to suggest the correct treatment options available for the patients.              

Point of Care Molecular Diagnostics Market Dynamics

Drivers

• Rising prevalence of infections

Growing incidence rate of infectious diseases and acute and chronic disorders is one of the major factors fostering the growth of the market. For example- increasing prevalence of cancer and HIV aids is directly influencing the market growth rate. In 2019, according to the Department of Health & Human Services, more than 38 million people were suffering from HIV aids.  

• Research and development proficiencies

Rising expenditure for research and development proficiencies especially in the developed and developing economies pertaining to the medical instruments and devices will further create lucrative market growth opportunities. Research and development proficiencies being conducted for the development of emergency healthcare services is also bolstering the market growth rate.

• Growing investment for healthcare facilities

Surging focus towards improving the condition of healthcare facilities and improving the overall healthcare infrastructure another important factor fostering the growth of the market. Rising number of partnerships and strategic collaborations between the public and private players pertaining to funding and application of new and improved technology is further creating lucrative market opportunities.

Opportunities

Furthermore, upsurge in the public-private funding for target research activities, rising conferences and exhibitions to raise awareness of robotic systems in pharmaceutical manufacturing, rising number of road accidents and rising product innovations and development owing to technological advancements all around the world will extend profitable opportunities for the market players in the forecast period of 2024 to 2031. Additionally, increased demand for collaborative robots in manufacturing facilities, rising internet penetration rate, rising need for home healthcare services and increasing per capita expenditure on health care will further expand the market's growth rate in the future. 

Restraints/Challenges

On the other hand, high cost associated with the research and development proficiencies, limited infrastructural facilities and dearth of awareness in the backward economies are expected to obstruct market growth. Also, lack of favorable reimbursement scenario and technology penetration in the developing economies, stringent regulatory hurdles pertaining to the point of care diagnostic test kits, lack of alignment with definitive central lab methods and lack of suitable infrastructure in low- and middle-income countries are projected to challenge the market in the forecast period of 2024-2031.

This point of care molecular diagnostics market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the point of care molecular diagnostics market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.

COVID-19 Impact on Point of Care Molecular Diagnostics Market

COVID-19 has stimulated the market growth rate in the upward direction. Increasing number of patients and booming hospitalization rate owing to the spread of virus is one of the biggest factors responsible for pushing up the market growth rate. Growing focus of the healthcare institutions to provide the best of facilities to the patients ensured a good run of the market in this pandemic. Further, rising global demand for diagnostic kits to rapidly detect the disease in this period created lucrative market growth opportunities. Moreover, increasing prevalence of other respiratory illnesses across the globe and improved access to point-of-care devices through online platforms further pushed the growth rate of the market.  

Point of Care Molecular Diagnostics Market Scope

The point of care molecular diagnostics market is segmented on the basis of product and services, technology, test location, application and end user. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.

Product and services

• Assays and Kits
• Instruments/Analyzers
• Software and Services

Technology

• Polymerase Chain Reaction-Based
• Genetic Sequencing-Based
• Hybridization-Based
• Microarray-Based
• Isothermal Nucleic Acid Amplification Technology (INAAT)
• Others

Test location

• Over The Counter
• Point of Care

Application

• Respiratory Diseases
• Sexually Transmitted Diseases
• Hospital-Acquired Infections
• Oncology
• Hepatitis
• Hematology
• Prenatal Testing
• Endocrinology
• Others

End user

• Physician Offices
• Hospital Emergency Departments and Intensive Care Units
• Research Institutes
• Home-Care
• Decentralized Labs
• Assisted Living Healthcare Facilities
• Others

Point of Care Molecular Diagnostics Market Regional Analysis

The point of care molecular diagnostics market is analyzed and market size insights and trends are provided by country, product and services, technology, test location, application and end user as referenced above.

The countries covered in the point of care molecular diagnostics market report are U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.

North America dominates the point of care molecular diagnostics market because of the strong base of healthcare facilities, increased adoption of advanced point of care molecular diagnostics solutions to detect infections diseases and rising number of research activities in this region.  

Espera-se que a Ásia-Pacífico testemunhe um crescimento significativo durante o período de previsão de 2024 a 2031 devido ao aumento das iniciativas governamentais para promover a sensibilização, ao aumento do turismo médico, às crescentes atividades de investigação na região, à disponibilidade de enormes mercados inexplorados, grande pool populacional, disponibilidade de infraestruturas bem estabelecidas, melhoria da taxa de adoção de diagnósticos moleculares no local de prestação de cuidados na Índia e na China e a crescente procura de cuidados de saúde de qualidade na região.

A secção do país do relatório também fornece fatores individuais de impacto no mercado e alterações na regulamentação do mercado interno que impactam as tendências atuais e futuras do mercado. Pontos de dados como a análise da cadeia de valor a jusante e a montante, tendências técnicas e análise das cinco forças de Porter, estudos de caso são alguns dos indicadores utilizados para prever o cenário de mercado para países individuais. Além disso, são considerados a presença e disponibilidade de marcas globais e os desafios enfrentados devido à grande ou escassa concorrência de marcas locais e nacionais, o impacto das tarifas nacionais e das rotas comerciais, ao mesmo tempo que se fornece uma análise de previsão dos dados do país.   

Participação no mercado de diagnóstico molecular de ponto de atendimento

O cenário competitivo do mercado de diagnóstico molecular no ponto de atendimento fornece detalhes por concorrente. Os detalhes incluídos são a visão geral da empresa, finanças da empresa, receitas geradas, potencial de mercado, investimento em investigação e desenvolvimento, novas iniciativas de mercado, presença global, localizações e instalações de produção, capacidades de produção, pontos fortes e fracos da empresa , lançamento de produto, largura e amplitude do produto, aplicação domínio. Os dados acima fornecidos estão apenas relacionados com o foco das empresas relacionado com o mercado de diagnóstico molecular no ponto de atendimento.

Os líderes de mercado de diagnóstico molecular de ponto de atendimento que operam no mercado são:

• Abbott (EUA)
• Siemens Healthineers AG (Alemanha)
• Quidel Corporation (EUA)
• F. Hoffman-La Roche Ltd. (Suíça)
• Danaher. (NÓS)
• BD (EUA)
• Chembio Diagnostics (EUA)
• Diagnóstico EKF (Reino Unido)
• Trinity Biotech plc (Irlanda)
• Laboratório de Instrumentação (EUA)
• Nova Biomedical (EUA)
• Diagnóstico PTS (EUA)
• Diagnóstico Sekisui (EUA)
• Thermo Fisher Scientific (EUA)
• bioMérieux SA (França)
• DiaSorin SpA (Itália)
• (China)
• Meridian Bioscience (EUA)
• Biocartis Biociências (Europa)
• GeneSTAT Molecular Diagnostics, LLC (EUA)
• Terumo Corporation (Japão)
• Grifols, SA (Espanha)

Últimos desenvolvimentos no mercado de diagnóstico molecular point of care

• Em fevereiro de 2022, a Sense Biodetection celebrou um acordo estratégico com a Una Health (Una) para a distribuição no Reino Unido do teste Veros Covid-19
• Em dezembro de 2021, a FIND investiu 21 milhões de dólares na Biomeme, Bioneer, Qlife e SD Biosensor para acelerar o desenvolvimento, fabrico e lançamento de plataformas de diagnóstico molecular no local de prestação de cuidados acessíveis que podem detetar vários agentes patogénicos que causam doenças, incluindo o COVID -19

SKU-26615